Centre proposes tighter regulatory oversight of antimicrobials to tackle drug resistance
Manufacturers would need central approval first as the ministry says weaker scrutiny has fueled safety risks and antimicrobial resistance.
- On Thursday, the Union Health Ministry proposed amending the New Drugs and Clinical Trials Rules, 2019, to bring antimicrobials under Central regulatory oversight through draft Gazette Notification G.S.R. 983 .
- Mounting concerns regarding antimicrobial resistance prompted the regulatory shift, as the Ministry flagged that antimicrobial products currently receive manufacturing licenses without adequate scrutiny, including bioavailability and stability studies.
- Separately, the Ministry proposed amendments to the Drugs Rules, 1945, introducing Form 19-BC and Form 20-BC for wholesale bulk drugs to strengthen supply chain accountability and oversight.
- Under the proposed framework, manufacturers must obtain permission from the Central Licensing Authority before applying for a license from the State Licensing Authority , strengthening central oversight.
- The Central Government issued a draft notification on November 6, inviting stakeholders and the public to submit objections and suggestions within 30 days before finalizing the amendments.
18 Articles
18 Articles
Union Ministry of Health proposes incorporation of Good Storage and Distribution Practices into Drugs Rules, 1945
New Delhi, Nov 19: The Union Ministry of Health and Family Welfare has proposed the incorporation of Good Storage and Distribution Practices (GSDP) guidelines for pharmaceutical products into the Drugs Rules, 1945. The proposal aims to ensure that the quality, safety, efficacy and integrity of pharmaceutical products are maintained throughout the distribution chain, from the manufacturer or importer to the point of supply to the patient. The pro…
The central government is going to change some rules related to the manufacture of medicines.
Health Ministry proposes to include antimicrobials in ‘New Drug’ definition, separate licence for bulk drug wholesale
Draft amendments to the New Drugs and Clinical Trials Rules, 2019, and the Drugs Rules, 1945, would require manufacturers of antimicrobials to obtain Central Licensing Authority permission before applying for a State licence, amid concerns over antimicrobial resistance, and introduce separate forms for the wholesale sale of bulk drugs
Centre proposes separate licensing framework for wholesale trade of bulk drugs
Stay updated with ThePrint: Preferred Source Google Discover New Delhi, Nov 19 (PTI) The Ministry of Health and Family Welfare has proposed a separate licensing framework for the wholesale trade of bulk drugs, including active and inactive bulk substances, to strengthen regulatory oversight and accountability in the pharmaceutical supply chain. The proposed amendments to the […]
Centre proposes tighter regulatory oversight of antimicrobials to tackle drug resistance
The Health Ministry has proposed amending the New Drugs and Clinical Trials Rules, 2019, to bring antimicrobials under Central regulatory oversight. The move would require manufacturers to secure prior approval from the Central Licensing Authority, addressing concerns over inadequate scrutiny and the growing threat of antimicrobial resistance.
Health ministry proposes amendment to drug rules to bring antimicrobials under regulatory oversight
Health ministry proposes amendment to drug rules to bring antimicrobials under regulatory oversight
Coverage Details
Bias Distribution
- 60% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium


















